A diverse portfolio of novel drug discovery efforts for Alzheimers disease: Meeting report from the 11th International Conference on Alzheimers Drug Discovery 27-28 September 2010 Jersey City NJ USA

摘要

While Alzheimer's disease researchers continue to debate the underlying cause(s) of the disease, most agree that a diverse, multi-target approach to treatment will be necessary. To this end, the Alzheimer's Drug Discovery Foundation (ADDF) recently hosted the 11th International Conference on Alzheimer's Drug Discovery to highlight the array of exciting efforts from the ADDF's funded investigators.